Condition
Bone Metastases From Solid Tumors
ClinicalTrials.gov condition label
Clinical trials
2 shownDevelopment of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid TumorsNCT07112989 · 2024-09-23
RECRUITINGSafety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone MetastasesNCT06069570 · 2023-11-07
RECRUITINGCommon interventions
Leading sponsors
Trial status mix
RECRUITING2
Phase mix
PHASE11
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.